Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Lupin Limited
LUPINLupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India and internationally. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, gynecology and women's health, central nervous system, oncology, immunology, genomics, metabolic disorders, dermatology, urology, pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies, as well as engages in the bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India. Address: Kalpataru Inspire, Mumbai, India, 400055
Analytics
Precio Objetivo de WallStreet
129 946.55 INRRelación P/E
45.6586Rentabilidad por dividendo
0.35 %Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave LUPIN
Análisis de dividendos LUPIN
Aumento del dividendo durante 5 años
-20 %Crecimiento continuo
1 AñoRatio de pago medio en 5 años
-2 %Tendencia del payout LUPIN
Valoración de la acción LUPIN
Finanzas LUPIN
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |